Another study demonstrated that JARID1B, a H3K4 demethylase that is expressed in a small subpopulation (5–10%) of the total cell population in aggressive primary and metastatic melanomas, may promote tumor maintenance by controlling cell proliferation [63]. Here, KDM5B is linked to neoplasm.